Novartis Wins Approval for Breast Cancer Drug

The FDA has granted approval for Novartis' drug Afinitor to be used as a treatment for breast cancer after it showed promise in clinical trials. More 

Retail Results Spoil the Day — Monday’s IP Market Recap

A disappointing retail report and mixed results for Citigroup's second quarter weighed on markets Monday, though M&A news sparked life into pharma. More 

Nestle’s is More Than Just Chocolate and Candy

NestlĂ© together with its subsidiaries, provides nutrition, health, and wellness products worldwide, and is an international dividend achiever. More 

Medidata Solutions a Strong Buy in Cloud Computing

Medidata Solutions is a fast-growing cloud services provider to the health care industry that is poised for even better growth and is a buying opportunity More 

Nestle: A Global Dividend Powerhouse

Nestle is a world wide brand name that produces products, earnings, and dividends at a remarkable rate every year. Nestle is a great portfolio buy. More 

Obesity: The Next Investment Driver

The global market for weight-control products of all types is forecast to hit $53 billion in just five years, and several companies are primed to profit. More 

Feel Safe Scooping Up Swiss Stocks

There's a lot to like about Switzerland as an investment haven. It's not a perfect environment, but a number of Swiss stocks look promising right now. More